Von Hippel-Lindau Disease: The Importance of Early Diagnosis and Treatment

Objectives: To provide an overview of Von Hippel-Lindau (VHL) disease, including its clinical presentation, treatment modalities, and follow-up protocols. To present a detailed analysis of patients within a family affected by VHL disease. To investigate challenges encountered in the treatment and follow-up of VHL disease, along with the optimal timing for treatment.
Methods: Diagnosis of patients was established through clinical examination, contrast-enhanced magnetic resonance imaging (MRI), and genetic testing. Surgical excision, radiotherapy, and chemotherapy were administered based on tumor localization, number, and size of lesions.
Results: VHL disease necessitates lifelong regular monitoring and treatment due to its chronic nature. Early diagnosis and planning for Gamma Knife treatment have been observed to lead to increased lifespan and improved quality of life for patients.
Conclusion: Early diagnosis and routine follow-up are crucial in managing VHL disease effectively. Multi-disciplinary approaches, including surgical intervention, radiotherapy, and chemotherapy, are essential in the treatment of VHL disease. Lifelong monitoring and treatment are necessary to optimize outcomes and improve the quality of life for individuals with VHL disease.